Shares of Merck KGaA (FRA:MRK) have been given an average rating of “Hold” by the twenty-two ratings firms that are covering the firm, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, fourteen have issued a hold recommendation and six have issued a buy recommendation on the company. The average 12-month price target among brokers that have issued a report on the stock in the last year is €109.25 ($128.53).
A number of research firms have recently weighed in on MRK. S&P Global set a €115.00 ($135.29) price target on Merck KGaA and gave the company a “neutral” rating in a report on Friday, May 19th. Credit Suisse Group set a €125.00 ($147.06) price target on Merck KGaA and gave the company a “buy” rating in a report on Monday, May 8th. Warburg Research set a €116.00 ($136.47) price target on Merck KGaA and gave the company a “neutral” rating in a report on Tuesday, June 20th. Deutsche Bank AG set a €106.00 ($124.71) price target on Merck KGaA and gave the company a “neutral” rating in a report on Wednesday, July 26th. Finally, Nord/LB set a €100.00 ($117.65) target price on Merck KGaA and gave the stock a “neutral” rating in a report on Thursday.
Merck KGaA (MRK) traded down 0.484% during mid-day trading on Friday, reaching €92.376. The company’s stock had a trading volume of 3,055 shares. The stock’s 50-day moving average is €101.69 and its 200-day moving average is €104.17. The firm has a market capitalization of €40.11 billion and a PE ratio of 25.753. Merck KGaA has a 12 month low of €89.00 and a 12 month high of €115.00.
ILLEGAL ACTIVITY WARNING: “Brokerages Set Merck KGaA (FRA:MRK) PT at $109.33” was originally published by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this story on another domain, it was stolen and reposted in violation of US & international copyright and trademark law. The legal version of this story can be read at https://stocknewstimes.com/2017/08/07/merck-kgaa-framrk-given-average-recommendation-of-hold-by-brokerages-updated.html.
About Merck KGaA
.
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
